Myrbetriq

Product NDC
70518-2435
11-digit product format
705182435
Labeler code
70518
Product ID
70518-2435_ea71feb1-4def-1170-e053-2a95a90a62e5
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
mirabegron
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
NDA202611
Marketing category
NDA
Marketing start
2019-11-19
Marketing end
0000-00-00
Substance
MIRABEGRON
Active strength
50 mg/1
Pharmacologic classes
Adrenergic beta3-Agonists [MoA], Cytochrome P450 2D6 Inhibitors [MoA], Cytochrome P450 3A Inhibitors [MoA], P-Glycoprotein Inhibitors [MoA], beta3-Adrenergic Agonist [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
70518-2435MYRBETRIQ (MIRABEGRON) TABLET, FILM COATED, EXTENDED RELEASE [REMEDYREPACK INC.]9Legacy NDC20250316_f499d877-7699-424d-bd74-7c12d1bad129.zip

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2435-07051824350090 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (70518-2435-0) 2019-11-190000-00-00NoNoCurrent
70518-2435-17051824350130 POUCH in 1 BOX (70518-2435-1) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-2435-2) 30 pouch2021-07-140000-00-00NoNoCurrent
70518-2435-37051824350330 POUCH in 1 BOX (70518-2435-3) > 1 TABLET, FILM COATED, EXTENDED RELEASE in 1 POUCH (70518-2435-4) 30 pouch2022-05-030000-00-00NoNoCurrent